JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells

被引:42
作者
Jin, Hui [1 ]
Lanning, Nathan J. [2 ]
Carter-Su, Christin [1 ,2 ]
机构
[1] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1210/me.2008-0015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Janus kinase 2 (JAK2), a tyrosine kinase that associates with the GH receptor and is activated by GH, has been implicated as a key mediator of GH signaling. Several published reports suggest that members of the Src family of tyrosine kinases may also participate in GH signaling. We therefore investigated the extent to which JAK2 and Src family kinases mediate GH activation of signal transducers and activators of transcription (STATs) 1, 3, and 5a/b, ERKs 1 and 2, and Akt, in the highly GHresponsive cell lines 3T3- F442A preadipocytes and H4IIE hepatoma cells. GH activation of Src family kinases was not detected in either cell line. Further, blocking basal activity of Src kinases with the Src inhibitors PP1 and PP2 did not inhibit GH activation of STATs 1, 3, or 5a/ b, or ERKs 1 and 2. When levels of JAK2 were depressed by short hairpin RNA in 3T3-F442A and H4IIE cells, GH- stimulated activation of STATs 1, 3, and 5a/ b, ERKs 1 and 2, and Akt were significantly reduced; however, basal activity of Src family kinases was unaffected. These results were supported genetically by experiments showing that GH robustly activates JAK2, STATs 3 and 5a/b, ERKs 1 and 2, and Akt in murine embryonic fibroblasts derived from Src/Yes/Fyn tripleknockout embryos that lack known Src kinases. These results strongly suggest that JAK2, but not Src family kinases, is critical for transducing these GH signals in 3T3- F442A and H4IIE cells.
引用
收藏
页码:1825 / 1841
页数:17
相关论文
共 87 条
[2]   GROWTH-HORMONE, INTERFERON-GAMMA, AND LEUKEMIA INHIBITORY FACTOR PROMOTED TYROSYL PHOSPHORYLATION OF INSULIN-RECEPTOR SUBSTRATE-1 [J].
ARGETSINGER, LS ;
HSU, GW ;
MYERS, MG ;
BILLESTRUP, N ;
WHITE, MF ;
CARTERSU, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14685-14692
[3]   IDENTIFICATION OF JAK2 AS A GROWTH-HORMONE RECEPTOR-ASSOCIATED TYROSINE KINASE [J].
ARGETSINGER, LS ;
CAMPBELL, GS ;
YANG, XN ;
WITTHUHN, BA ;
SILVENNOINEN, O ;
IHLE, JN ;
CARTERSU, C .
CELL, 1993, 74 (02) :237-244
[4]   Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling [J].
Argetsinger, LS ;
Norstedt, G ;
Billestrup, N ;
White, MF ;
CarterSu, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29415-29421
[5]   The specificities of protein kinase inhibitors: an update [J].
Bain, J ;
McLauchlan, H ;
Elliott, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2003, 371 :199-204
[6]   The selectivity of protein kinase inhibitors: a further update [J].
Bain, Jenny ;
Plater, Lorna ;
Elliott, Matt ;
Shpiro, Natalia ;
Hastie, C. James ;
Mclauchlan, Hilary ;
Klevernic, Iva ;
Arthur, J. Simon C. ;
Alessi, Dario R. ;
Cohen, Philip .
BIOCHEMICAL JOURNAL, 2007, 408 :297-315
[7]   Effects of growth hormone overexpression and growth hormone resistance on neuroendocrine and reproductive functions in transgenic and knock-out mice [J].
Bartke, A ;
Chandrashekar, V ;
Turyn, D ;
Steger, RW ;
Debeljuk, L ;
Winters, TA ;
Mattison, JA ;
Danilovich, NA ;
Croson, W ;
Wernsing, DR ;
Kopchick, JJ .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (02) :113-123
[8]   Leukocyte protein tyrosine kinases: Potential targets for drug discovery [J].
Bolen, JB ;
Brugge, JS .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :371-404
[9]   Model for growth hormone receptor activation based on subunit rotation within a receptor dimer [J].
Brown, RJ ;
Adams, JJ ;
Pelekanos, RA ;
Wan, Y ;
McKinstry, WJ ;
Palethorpe, K ;
Seeber, RM ;
Monks, TA ;
Eidne, KA ;
Parker, MW ;
Waters, MJ .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2005, 12 (09) :814-821
[10]  
CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074